#eli-lilly

[ follow ]
#weight-loss-drugs
more#weight-loss-drugs
fromFast Company
1 month ago

Eli Lilly is making it cheaper and easier to buy high-doses of blockbuster weight-loss drug Zepbound

"Obesity is a serious, chronic disease, and access to obesity medications should be treated with the same urgency as other chronic conditions," said Rhonda Pacheco, emphasizing the importance of medication access.
Wearables
#pharmaceuticals
Healthcare
fromBusiness Insider
5 months ago

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.
Healthcare
fromBusiness Insider
5 months ago

New weight-loss drugs like Mounjaro are hot right now. Eli Lilly's CEO explains why they're so expensive.

Weight-loss drugs are expensive due to the high development costs and the limited time to recoup investment before patents expire.
more#pharmaceuticals
Startup companies
from24/7 Wall St.
1 month ago

Visa, Eli Lilly or Netflix- Which Stock Will Be A Trillion Dollar Company Next?

Visa, Netflix, and Eli Lilly are contenders for the trillion-dollar club, each poised for significant market growth.
Intellectual property law
fromAbove the Law
2 months ago

Patenting Privation (Part III): Empowering Revenge - Above the Law

The FDA's lifting of the shortage declaration has curtailed bulk sales of competing diabetes medications, impacting telehealth revenues significantly.
#novo-nordisk
more#novo-nordisk
from24/7 Wall St.
3 months ago

Eli Lilly Will Be the Next $1 Trillion Stock

Eli Lilly is on track to become the first healthcare company to reach a $1 trillion market cap, driven by its dominance in the GLP-1 market.
London startup
#zepbound
more#zepbound
#orforglipron
Wearables
fromNew York Post
3 months ago

Everything to know about the new weight loss pill that works as well as Ozempic - and when you can get it

Eli Lilly's orforglipron offers a stab-free treatment for diabetes and obesity, with potential FDA approval enhancing its market presence.
Wearables
fromwww.nytimes.com
3 months ago

What to Know About Eli Lilly's Daily Pill for Weight Loss

Eli Lilly's orforglipron offers a potential oral treatment for obesity and diabetes, expanding access beyond current injected options.
Wearables
fromBusiness Insider
3 months ago

Weight loss in a pill? Eli Lilly just took a big step closer to making it happen

Orforglipron, a new oral GLP-1 drug from Eli Lilly, may transform obesity treatment by offering a non-injection alternative.
more#orforglipron
from24/7 Wall St.
3 months ago

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025)

From late 2020 to the summer of 2024, Eli Lilly & Co. stock surged over 635%, driven by innovative medicines and regulatory successes, despite recent revenue shortfalls.
London startup
#stock-market
from24/7 Wall St.
3 months ago
Cryptocurrency

Here's Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today

from24/7 Wall St.
3 months ago
Cryptocurrency

Here's Why Eli Lilly (NYSE: LLY). Fidelity National (NYSE: FIS) and Diamondback Energy (Nasdaq: FANG) Are Soaring Today

more#stock-market
fromNew York Post
3 months ago

Eli Lilly stock surges 15% after clinical trial of weight loss pill shows it works like Ozempic

"The drug also lowered patients' blood sugar levels by 1.3% on average, while the overall efficacy of orforglipron in promoting weight loss and controlling diabetes has been met with enthusiasm."
Wearables
from24/7 Wall St.
3 months ago

These 2 Dividend Giants Are at 52-Week Lows. Time to Buy?

That's where being a savvy investor comes in. Being contrarian, you can pick up these hidden gems at a significant discount and profit all the way to the bank when their fortunes turn.
Startup companies
Exercise
fromwww.nytimes.com
4 months ago

Eli Lilly Drug Reduces Mysterious Lp(a) Particle Involved in Heart Attack Risk

Eli Lilly's experimental drug lepodisiran significantly reduces harmful Lp(a) levels in the blood, potentially aiding cardiovascular health.
US politics
fromwww.aljazeera.com
5 months ago

Eli Lilly plans $27bn in new plants as Trump threatens pharma tariffs

Eli Lilly plans to invest $27 billion in new US plants, creating over 3,000 skilled jobs and responding to potential drug import tariffs.
Medicine
fromAdweek
6 months ago

R/GA Wins Eli Lilly Social Business

Eli Lilly has appointed R/GA to manage social media for its Zepbound weight-loss drug and other brands.
FDA approval of Zepbound opens a new market for Eli Lilly in sleep apnea treatment.
Medicine
fromFast Company
7 months ago

Novo Nordisk stock price takes a tumble after the Wegovy maker's next-generation weight-loss drug underwhelms

CagriSema failed to meet weight loss expectations in trials, causing significant stock decline for Novo Nordisk.
[ Load more ]